Stock listing
NASDAQ:RLYP Relypsa Inc Stock
Follow Relypsa Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RLYP
$31.99 USD
Close on Aug 31, 2016 · No longer trades
- Lowest – highest close
- $11.76 – $46.05 USDSince Nov 15, 2013 · lowest Oct 22, 2015 · highest Mar 18, 2014
Delisted NASDAQ:RLYP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RLYP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Scott Garland Other companies: Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Jan 7, 2026); LB Pharmaceuticals Inc (Chairman of the Board, LB Pharmaceuticals · Since at least Sep 10, 2025); Olema Pharmaceuticals, Inc. (Director · Since at least Oct 16, 2023); ALX Oncology Holdings Inc. (Chairman · Since at least Nov 28, 2022); Day One Biopharmaceuticals Inc (Director · Since at least Aug 16, 2021); Calithera Biosciences, Inc. (Director · Jul 10, 2020 – Jun 1, 2022 · Past); Portola Pharmaceuticals Inc (President and CEO, Director · Oct 8, 2018 – Jul 2, 2020 · Past); Karyopharm Therapeutics Inc. (Director · Nov 3, 2014 – Jun 6, 2019 · Past); Exelixis, Inc. (EVP & Chief Commerical Officer · Oct 20, 2011 – Sep 18, 2013 · Past) | SVP & Chief Commercial Officer · Oct 31, 2014 – Sep 1, 2016 · Past |
| David McGirr Other companies: X4 Pharmaceuticals, Inc. (Director · Since at least Nov 15, 2017); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Insmed Incorporated (Director · Since at least Oct 30, 2013); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Cubist Pharmaceuticals Inc (SVP & Chief Financial Officer · Mar 31, 2010 – Feb 15, 2013 · Past) | Director · Nov 14, 2013 – Sep 1, 2016 · Past |
| Scott M Rocklage Other companies: Aprea Therapeutics, Inc. (Director · Oct 2, 2019 – Jun 30, 2020 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – Feb 3, 2016 · Past); Cidara Therapeutics Inc (Director · Apr 14, 2015 – Jun 13, 2018 · Past); EPIRUS Biopharmaceuticals Inc (Director · Jul 15, 2014 – Jun 5, 2015 · Past); Achaogen Inc (Director · Mar 11, 2014 – Mar 11, 2014 · Past) | Director · Nov 14, 2013 – Nov 20, 2013 · Past |
| Kenneth J Hillan Other companies: Sangamo Therapeutics, Inc. (Director · Since at least Sep 9, 2020); 23Andme Holding Co (Chief Therapeutics Officer · Jun 16, 2021 – Jun 5, 2023 · Past); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 7, 2023 · Past); Achaogen Inc (See Remarks, Director · Mar 11, 2014 – Jun 28, 2018 · Past) | Director · Jun 19, 2014 – Sep 1, 2016 · Past |
| Kristine Ball Other companies: Enliven Therapeutics, Inc. (Member of the Board of Directors · Since at least Oct 14, 2026); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Atreca Inc (Director · May 20, 2020 – Jun 13, 2023 · Past); Forty Seven Inc (Director · Jun 27, 2018 – Apr 7, 2020 · Past) | Chief Financial Officer & SVP · Nov 14, 2013 – Sep 1, 2016 · Past |
| Thomas J. Schuetz Other companies: Compass Therapeutics, Inc. (Chief Executive Officer, Compass Therapeutics · Since at least Jun 17, 2020); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Jan 15, 2020 · Past) | Director · Nov 14, 2013 – Sep 1, 2016 · Past |
| Mary Corbett | Senior VP, Human Resources · Jun 3, 2016 – Sep 1, 2016 · Past |
| Monte Montgomery | Chief Accounting Officer · Aug 1, 2016 – Sep 1, 2016 · Past |
Log in to ask 6ix AI your own questions about Relypsa Inc.